Skip to main content

Advertisement

Table 1 Clinical and pathological data for breast tumours analysed by microarray

From: MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancer

Number ID Age (years) Tsize (mm) Lymph node status Grade UICC stage ER PR HER2/neu Subtype
1 52 49 23 Negative 1 2A P P N Luminal A
2 53 52 30 Negative 3 2A N N P Her2 overexpressing
3 54 57 45 Negative 3 2A N N P Her2 overexpressing
4 56 51 21 Negative 3 2A P P N Luminal A
5 58 68 15 Negative 3 1 P N N Luminal A
6 59 42 22 Negative 3 2A N N N Triple negative
7 60 54 26 Negative 3 2A N P N Luminal A
8 61 35 22 Negative 3 2A P P N Luminal A
9 62 50 16 Negative 3 1 N N N Triple negative
10 63 49 25 Negative 2 2A N N N Triple negative
11 64 59 20 Negative 3 1 N P N Luminal A
12 65 58 22 Negative 3 2A P P N Luminal A
13 66 58 18 Negative 1 1 N P P Her2 overexpressing
14 67 66 22 Negative 3 2A P P N Luminal A
15 94 56 17 Negative 1 1 N N N Triple negative
16 95 48 30 Negative 3 2A N N P Her2 overexpressing
17 96 60 26 Negative 3 2A P P N Luminal A
18 97 56 29 Negative 2 2A P P N Luminal A
19 98 50 3 Negative 2 1 P P N Luminal A
20 99 40 7 Negative 1 1 P P N Luminal A
21 100 40 6 Negative 2 1 P P N Luminal A
22 101 58 35 Negative 2 2A P P N Luminal A
23 102 64 34 Negative 3 2A P P N Luminal A
24 103 66 26 Negative 1 2A P P N Luminal A
25 104 84 16 Negative 2 1 N P N Luminal A
26 105 57 7 Negative 3 1 N P N Luminal A
27 106 68 35 Negative 3 2A P P N Luminal A
28 107 40 20 Negative 2 1 P P P Luminal B
29 108 49 35 Negative 3 2A N N N Triple negative
  1. ER, oestrogen receptor; HER2/neu, v-erb-b2 erythroblastic leukaemia viral oncogene homolog 2 receptors; ID, identification; N, negative confirmed; PR, progesterone receptor; P, positive confirmed; Tsize, Tumour size in mm; UICC, stage of breast tumour according to the international union against cancer staging criteria.